A comparison of severe pre-eclampsia/eclampsia in patients with and without HELLP syndrome by Zuberi, N F et al.
eCommons@AKU
Department of Obstetrics & Gynaecology Division of Woman and Child Health
February 1998
A comparison of severe pre-eclampsia/eclampsia in
patients with and without HELLP syndrome
N F. Zuberi
Aga Khan University, nadeem.zuberi@aku.edu
K Arif
Aga Khan University, khurram.arif@aku.edu
F M. Khan
Aga Khan University
J A. Pal
Aga Khan University
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_obstet_gynaecol
Part of the Obstetrics and Gynecology Commons
Recommended Citation
Zuberi, N. F., Arif, K., Khan, F. M., Pal, J. A. (1998). A comparison of severe pre-eclampsia/eclampsia in patients with and without
HELLP syndrome. Journal of Pakistan Medical Association, 48(2), 29-32.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_obstet_gynaecol/98
A Comparison of Severe Pre-Eclampsia/Edampsia in Patients
with and without HELLP Syndrome
Pages with reference to book, From 29 To 32 
Nadeem F. Zuberi,Khuram Arif,Faraz M.Khan,Jehan A. Pal ( Department of Obstetrics and Glynaccology, The Aga Khan
University Hospital, Karachi. )
Abstract 
Background: The relationship of Haemolysis, Elevated Liver Enzymes and Low Platelets (HELLP)
syndrome with maternal and perinatal health and its presentation in Pakistani population is not known.
Purpose: To determine the mode of presentation alongwith maternal and perinatal outcome of patients
with HELLP syndrome.
Methods: Case records of patients with severe hypertension in pregnancy who delivered between
January 1, 1989 and December 31,1994 at The Aga Khan University Hospital, Karachi. Out of 120
cases of severe pre-eclampsia/eclampsia, there were 36 cases of HELLP syndrome (Group-A). These
were then compared with cases without HELLP syndrome (Group B) for their mode of presentation
alongwith maternal and perinatal morbidity and mortality.
Results: The overall incidence of HELLP syndrome was 0.4%. In the antepartum factors; unbooked
status (66% vs 30%; p<0.05), diastolic B.P. >120 mmHg (61% vs 16%; p=0.05) DIC (13% vs 2%;
p=0.03), seizures (40% vs 16%, p=0.01) and ARF (11%. vs 1%, p=0.07) were significantly raised.In
the intrapartum factors there were no significant differences between the two groups in mode of
delivery and complications of delivery. Neonatal outcomes did not differ significantly in the two
groups.
Conclusions: Women with severe hypertension in pregnancy manifesting with HELLP syndrome show
a significantly greater frequency of developing DIC, seizures and acute renal failure. Therefore, their
care necessitates intensive monitoring to preclude development of these complications (JPMA
48:29,1998).
Introduction 
HIELLP syndrome represents a disease entity incorporating Hemolysis, Elevated Liver Enzymes and
Low Platelets1-4 is seen in sqme cases of pregnancy induced hypertension. Literature describes its two
variants as HEL and ELLP4. The etiology is poorly understood and as yet no single precipitating factor
has been isolated. HELLP syndrome is hypothesized to be a collection of various clinical and
pathological nmnifestations secondary to an insult that leads to intravascular platelet activation and
microvascular endothelial damage. The activation of platelets results in the release of thromboxane A2
and serotonin causing vasospasm, platelet aggregation and further endothelial injury. Progressive
damage to the endothelial integrity leads to reduced prostacyclin production and enhanced surface
mediated platelet activation. Thus a vicious cycle of progressively worsening DIC is generated which
can only be disrupted by termination of pregnancy5. There is considerable paucity of literature in the
subcontinent on the HELLP syndrome and its variants. It has been described as an early fonn of pre-
eclanipsia4; as a unique variant of pre-eclampsia6 and even as misdiagnosed pre-eclampsia7. There
exists an urgent need to determine the significance of HELLP syndrome in maternal and perinatal
mortality resulting from severe pre-eclampsia/eclampsia. Possible predisposing and aggravating factors
for this syndrome need to be isolated and differences in the presentation and outcome of this disease, in
Pakistan need to be elucidated. Considering these factors along’with the varied presentations of HELLP
syndrome and the delay in its early diagnosis and management, a retrospective study was conducted on
all cases of pre-eclarnpsia/eclampsiawithandwithout HELLP syndrome. Specific objectives were
consideration of the frequency, mode of presentation and the maternal and perinatal outcome of
patients with severe pre- eclampsia/eclampsia.
Patients and Methods 
The study population consisted of all women who delivered between January 1, 1989 and December31,
1994 at The Aga Khan University Hospital, Karachi. This is a tertiary health care centre which doubles
as a teaching hospital, with approximately 2500 deliveries per year. The patients in the study were
either being followed during their pregnancies at the antenatal clinics of the hospital (booked patients)
or they were referred for pen and post parturn management from centres elsewhere in the city
(unbooked patients). During the six year period 10,366 women were delivered at the institution, of
these, 621 (6%) were identified to have pre-eclanipsia/eclampsia, of which 120 patients had severe pre-
eclampsia/eclampsia (diastolic B.P.> 110 mrnHg). This group was subdivided into Group-A and Group-
B. Patients with HELLP syndrome comprised Group-A, while those having severe pre-
eclampsia/eclampsia without HELLP were designated Group-B. HELLP syndrome was diagnosed
according to the criteria of Sibai et al8 (Table 1).
Data was collected by reviewing the medical record files of these patients and their babies. Statistical
analysis involved computing. the frequencies and percentages of our variables. Chi square tests of
independence and Fisher Exact Two Tail tests were perfonned with 95% confidence interval and an
alpha error of 0.5%, p value was significant if <0.05. The patients were managed in the labour room or
in the emergency room at first contact. After stabilization they were transferred to the high risk
antenatal ward for further management. First line therapy for controlling severe hypertension i.e.,
diastolic
Hernoiysis
Abnormal Peripheral Blood Smear with Nucleated RBC’s
Total Bilirubin >1.2 mgfdl
Lactic Dehydrogenase (LDH)>600 UIL
Elevated Liver Function Tests:
Serum Glutamic Oxaloacetic Transaminase (SOOT) >70 U/L
Lactic Dehydrogenase(LDH)>600 U/L
Low Platelets:
Platelet Count <100,000/mm3
Sibai et al4
B.P. >110 mmHg was intravenous infusion of Hydralazine/sublingual Nifidepine. Subsequent control
of hypertension was achieved by oral MethyldopafHydralazine/ Nifidepine depending upon the need
for continuation of pregnancy. For seizures intravenous Magnesium sulphate or Diazepam was used
depending upon the preference of the consultant. The management of Disseminated Intravascular micro
Coagulation with haemorrhagic tendencies (DIC) involved symptomatic therapy depending upon the
predominance of coagulopathy and bleeding diathesis.
Results 
Of 120 patients with severe pre-eclampsia/eclampsia, 38 were cases of HELLP syndrome. The overall
incidence of HELLP syndrome in 10,366 deliveries was 0.4%.
Table II displays mean maternal age, gestational age, parity and mode of presentation with no
significant statistical difference in these parameters. However, it was seen that women in Group-A (6
1%) had a significantly raised diastolic blood pressure (>120 mmHg) as compared to Group-B (16%).
Significantly more patients with HELLP syndrome were unbooked as opposed to the control group
(66% vs 30%).
Table III lists the various factors contributing to maternal morbidity associated with severe pre-
eclampsia/eclampsia in patients with and without HELLP syndrome. In the antepartum factors DIC,
seizures and acute renal failure significantly increased morbidity (p<0.05) in Group-A as compared to
Group-B. Among the intnipartum factors no significant difference was seen in the mode of delivery
between the two groups. There was no maternal mortality in either of the groups5.
Table IV presents a comparison of neonatal outcomes between Group-A and Group-B. The perinatal
mortality rate in the 1{ELLP group was 15.7%, perinatal asphyxia was 21 .1%and the intrauterine
death 5.2%. Of the patients with HELLP syndrome, 24% had small for gestational age babies. It was
seen that mothers in the HELLP syndrome group had a higherpercentage of babies with poor5 min
Apgar scores, more babies requiring neonatal intensive care, a greater number of intrauterine deaths
and higher neonatal mortality as compared to the control group of severe
pre-eclanipsia/eclampsia. The percentage of female births as compared to male births was higher in
both the groups.
Discussion 
Literature reports over400 studies have been carried out on the HELLP syndrome but so far none from
the developing countries of South East Asia. Pre-eclampsia and eclampsia form a major high risk group
in the third world countries and there seems great likelihood of HELLP syndrome with high maternal
and perinatal morbidity8 complicating a large number of these cases. The description and the mode of
presentation and severity as measured by maternal and perinatal outcome of HELLP syndrome in
developing countries must be looked into. Our study gave an overall prevalence ofHELLP syndrome
and the percentage of women with pre-eclampsia/eclampsia manifesting HELLP syndrome as
comparable to previous studies in the obstetric literature5,7,9,10,11,12 Although the literature reports the
presence of HELLP syndrome even in patients without hypertension13,14. Our group targeted only
patients with preeclampsia for the screening of HELLP syndrome. This study also showed that patients
who received little or no antenatal care were at a higher risk of developing HELLP syndrome as
opposed to those attending regular antenatal clinics. In the mode of presentation while diastolic blood
pressure >110 mmHg was present in significantly more patients from Group-A than Group-B, right
upper quadrant pain, marked proteinuria, malaise and headache were present in greater frequency
among the group with HELLP syndrome as opposed to the severe pre-eclampsia/eclampsia group
without HELLP syndrome3,5,7,11,13.
This fact highlights the importance of early intervention in reducing morbidity from HELLP. Although
right upper quadrant pain was present with greater frequency in Group-A as opposed to Group-B,
nevertheless both right upper quadrant pain and nausea/vomiting were seen in only 26% of HELLP
syndrome cases. Nearly one third of our patients with HELLP syndrome were pnmigravidae a
percentage greater than seen in previous studies where multigravidae comprise the overwhelming
majority of HELLP patients8. Mean maternal age and mean gestational age are comparable to those
reported in the literature8. The outcome of our patients was again comparable with previous literature
both in maternal and perinatal aspects. We observed that a significantly greater number of the patients
with HELLP suffered from risk of developing seizures, acute renal failure (ARF) and disseminated
intravascular coagulation (DIC), a trend seen previously8. The perinatal asphyxia rate, intrauterine
death rate15 and the perinatal mortality rate16 closely reflected previously quoted figures for the group
of patients with HELLP. However, these statistics did not differ significantly from those of severe pre-
eclampsia eclampsia group. This shows that in future studies on perinatal outcome of HELLP patients
should simultaneously look at patients with severe pre- eclampsia/eclampsia to pick out any significant
differences between the two groups of patients with regards to pennatal parameters. Of our neonates
from the HELLP group small for gestational age, incidence was similar to some previous literature8,
yet contrasting with our reports15. Although the risk for birth asphyxia. neonatal intensive care
requirement, IUD and NND was higher in Group-A as opposed to Group-B, the difference was not
significant.
In light of the various factors that have come forward from our study, we recommend that HELLP
syndrome be treated as a serious clinical entity associated with an incidence of high maternal and
perinatal morbidity and that it should receive the same serious attention in developing countries as it
has received in the West. We also recommend that since all of our cases of HELLP were seen in the
group of severe pre-eclampsia/eclampsia, this group should be targeted as being at the highest risk for
development of this syndrome. This will enable us to screen for HELLP in a manner which is both cost
effective and resource efficient, a consideration that is of particular importance in a developing country.
Nevertheless, we would like to point out that the section of the population represented by our study is
highly skewed since we see only those cases referred from other centres or picked up
through our own antenatal clinics. It is recommended that centres in other parts of the country and in
South East Asia be motivated to study the incidence of HELLP syndrome since it has been shown that
early recognition of this entity can help reduce maternal morbidity and perinatal mortality. It is
important that physicians include this disease in the gamut of illnesses that they are likely to face in this
part of the world.
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